PUBLISHER: IMARC | PRODUCT CODE: 1820187
PUBLISHER: IMARC | PRODUCT CODE: 1820187
The global probiotic drinks market size reached USD 17.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 26.9 Billion by 2033, exhibiting a growth rate (CAGR) of 4.64% during 2025-2033.
Probiotic drinks refer to a functional beverage consisting of specific microorganisms, which are beneficial for human health. They are manufactured by adding water, sugar, herbal or fruit extracts to the probiotic culture of bacteria and yeast and processing it through bio-fermentation. The probiotics multiply by absorbing the added sugar and stop when they reach the multiplication peak. These microorganisms promote the overall gut health by maintaining the natural balance of organisms in the intestines and also aid in improving immunity. Apart from this, regular consumption of probiotic drinks also facilitates effective nutrient absorption and preventing and treating gastrointestinal issues (GI), including diarrhea, constipation and irritable bowel syndrome (IBS).
The increasing prevalence of gastrointestinal disorders, along with the rising health consciousness among the masses, represents one of the key factors driving the growth of the market. There is a shift in the consumer preference from carbonated drinks to ready-to-drink (RTD) functional beverages and probiotic drinks as they have a high nutritional and low-calorie content. In line with this, the increasing demand for immunity boosting and probiotic fortified dietary supplements and functional food products due to the onset of coronavirus disease (COVID 19) is also contributing to the growth of the market. Additionally, various product innovations, such as the launch of probiotic drinks in exotic flavors and attractive packaging, are acting as other growth-inducing factors. Product manufacturers are also adopting aggressive promotional activities through the online retail and e-commerce platforms, thereby favoring the market growth. Other factors, including rising healthcare expenditures of the consumers, along with extensive research and development (R&D) activities, are anticipated to drive the market further.
The competitive landscape of the industry has also been examined along with the profiles of the key players being Amul (GCMMF), Bio-K Plus International Inc., Chobani LLC, Danone S.A., Fonterra Co-operative Group, Harmless Harvest Inc., Kevita Inc. (Pepsico Inc.), Lifeway Foods Inc., Nestle SA, NextFoods and Yakult Honsha Co. Ltd.